Trials / Conditions / Relapsed/Refractory Multiple Myeloma(MM)
Relapsed/Refractory Multiple Myeloma(MM)
5 registered clinical trials studyying Relapsed/Refractory Multiple Myeloma(MM) — 4 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Clinical Study of BCMA-Targeted CAR T-Cell Injection in the Treatment of Patients With Relapsed/Refractory Mul NCT07458659 | Chulalongkorn University | EARLY_Phase 1 |
| Recruiting | Study of Naive HBI0101 CAR-T Therapy in Relapsed/Refractory Multiple Myeloma NCT07333430 | Hadassah Medical Organization | Phase 1 |
| Recruiting | LCAR-F33S in Treatment of Relapsed/Refractory Multiple Myeloma NCT07100067 | Nanjing Legend Biotech Co. | N/A |
| Recruiting | Allogeneic UCB-derived, Dual-targeting BCMA/CD19 CAR-T for Relapsed/Refractory Multiple Myeloma NCT07139509 | Xi'an No.3 Hospital | Phase 1 |
| Terminated | CAR-T Cells Therapy in Relapsed/Refractory Multiple Myeloma NCT03473496 | Zhujiang Hospital | N/A |